This paper is in the following e-collection/theme issue:

Reviews on Usage or other Formative Evaluation Metrics (44) Cost-Effectiveness and Economics (252) Implantable Drug Delivery Systems, Ingestible Sensors and Digital Pills (15) Gastroenterology and Hepatology (68)

Published on in Vol 5, No 1 (2021): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13888, first published .
Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

Authors of this article:

Mattias Neyt1 Author Orcid Image ;   Annick Christiaens2 Author Orcid Image ;   Marina Aloi3 Author Orcid Image ;   Lissy de Ridder4 Author Orcid Image ;   Nicholas M Croft5 Author Orcid Image ;   Sibylle Koletzko6, 7 Author Orcid Image ;   Arie Levine8 Author Orcid Image ;   Dan Turner9 Author Orcid Image ;   Richard K Russell10 Author Orcid Image ;   Frank M Ruemmele11, 12 Author Orcid Image ;   Gigi Veereman13 Author Orcid Image
Article Authors Cited by Tweetations (3) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.